FORMA THERAPEUTICS HOLDINGS (FMTX) Stock Analyst Ratings

NASDAQ:FMTX • US34633R1041

20.01 USD
+0.03 (+0.15%)
At close: Oct 13, 2022
20.01 USD
0 (0%)
After Hours: 10/13/2022, 8:24:26 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to FMTX. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 21.01. This target is 5.01% above the current price.
  • FMTX was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about FMTX.
  • In the previous month the buy percentage consensus was at a similar level.
  • FMTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
FMTX Historical Analyst RatingsFMTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 20.0120.2020.4021.0124.15 - 0.95% 1.95% 5.01% 20.69%

Related screens

Find peers 30% below price target
FMTX Current Analyst RatingFMTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2022-09-02 Oppenheimer Downgrade Outperform -> Perform
2022-09-02 Credit Suisse Downgrade Outperform -> Neutral
2022-09-02 Jefferies Downgrade Buy -> Hold
2022-09-02 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-05-27 SVB Leerink Maintains Outperform
2021-11-12 SVB Leerink Maintains Outperform
2021-08-17 HC Wainwright & Co. Maintains Buy
2021-08-02 Craig-Hallum Initiate Buy
2021-06-11 SVB Leerink Maintains Outperform
2021-03-31 HC Wainwright & Co. Maintains Buy

FORMA THERAPEUTICS HOLDINGS / FMTX FAQ

What do analysts expect the price target to be for FORMA THERAPEUTICS HOLDINGS (FMTX)?

12 analysts have analysed FMTX and the average price target is 21.01 USD. This implies a price increase of 5.01% is expected in the next year compared to the current price of 20.01.


What is the consensus rating for FORMA THERAPEUTICS HOLDINGS (FMTX) stock?

The consensus rating for FORMA THERAPEUTICS HOLDINGS (FMTX) is 75 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover FORMA THERAPEUTICS HOLDINGS (FMTX) stock?

The number of analysts covering FORMA THERAPEUTICS HOLDINGS (FMTX) is 12.